Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by 1hot-techwomanon Sep 09, 2024 2:21pm
59 Views
Post# 36215171

RE:Trump Supports Rescheduling and Banking !!!! $$$$

RE:Trump Supports Rescheduling and Banking !!!! $$$$
1hot-techwoman wrote: https://www.youtube.com/watch?v=znwkPMqKSxA

DJ Marijuana Stocks Climb After Trump Claims Support for Cannabis Reform

Monday, September 9, 2024, 1:10 PM ET
 
 	

By Dean Seal
 	

Shares of cannabis stocks have a strong start to the week after former President Donald Trump said he would support marijuana overhaul, easing concerns that he might undo the Biden administration's efforts to loosen regulations if he wins the presidency in November.

AdvisorShares Pure US Cannabis, a popular exchange-traded fund tracking marijuana stocks, was up 10% at $7.08 on Monday. The two biggest U.S. cannabis companies by market capitalization, Curaleaf Holdings and Green Thumb Industries, were up 12% and 8.8% respectively.

The stocks of other big cannabis companies, including Tilray Brands, Verano Holdings and Trulieve Cannabis, were up 6% to 12%.

Trump said Sunday night in a post on his social-media website Truth Social that he supports federally reclassifying marijuana as a less dangerous drug, as the Department of Health and Human Services has recommended. The Drug Enforcement Administration is reviewing a proposal to do so, with a hearing scheduled for Dec. 2.

The agency's scheduling of the hearing past Election Day roused concerns that a new president might disrupt the Biden administration-led overhaul. Vice President Kamala Harris, the Democratic nominee, has vowed to be a strong pro-pot advocate if elected.

Trump is now doing the same, adding in his post that he planned to vote in favor of legalizing cannabis in Florida, his adopted home state, when it is on the ballot this fall. Trump further said that he wanted to end arrests and incarcerations of adults for possessing small amounts of marijuana for personal use.

David Culver, the senior vice president of public affairs at the U.S. Cannabis Council, said in a statement that he looked forward to hearing more from Trump about how he would approach cannabis reform if elected.

"For the first time in history, both major party candidates support large-scale cannabis reform," Culver said.

<< Previous
Bullboard Posts
Next >>